SEPTEMBER 18, 2024
SYDNEY, AUSTRALIA
GEODIS, a world leader in transport and logistics, obtains IATA’s Centre of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification in Australia. With healthcare as a key strategic growth sector, GEODIS is committed to achieving pharmaceutical handling excellence in ensuring safety, security, compliance, and efficiency through a globally consistent and recognized pharmaceutical-product handling standard throughout the region.
In the APAC and Middle East region, the newly certified Sydney site joins the existing regional network of CEIV Pharma-certified locations in China (PVG), Indonesia (CGK), India (DEL & BOM), South Korea (ICN), Thailand (BKK), United Arab Emirates (DXB) and Singapore (SIN). GEODIS now operates a total of 29 CEIV Pharma certified sites across its global network spanning the Americas, Asia Pacific, the Middle East, and Europe. These certifications highlight the substantial investment GEODIS has made in its healthcare capabilities, establishing GEODIS as a key provider for pharma and healthcare companies.
Stuart Asplet, Managing Director of GEODIS Australia & New Zealand said, “The achievement of the CEIV Pharma accreditation underscores our commitment to delivering the highest standards in handling and transporting our customers’ high-value, time and temperature-sensitive cargo. This certification ensures compliance with regulatory requirements to safeguard the integrity of pharmaceutical products to their destination. Optimizing the supply chain with the IATA CEIV Pharma certification also aligns with GEODIS’ commitment to always find “A better way to deliver”.
With Australia’s pharmaceutical market projected to reach US$10.6 billion in 2024, and continue growing at 5.03% annually from 2024 to 2029*, GEODIS is well-positioned to support this growth and meet customer’s needs. The Sydney facility provides temperature-controlled cross-docking services in the +2°C to +8°C and +15°C to +25° ranges, complemented by comprehensive air, ocean, and customs solutions. It is part of GEODIS’ growing worldwide network for ambient and cold chain products, with further plans to gain the CEIV Pharma certification for New Zealand in the coming months.
As a growth partner to many leading pharmaceutical companies globally, GEODIS provides end-to-end compliant logistics solutions across the entire healthcare supply chain, from customs brokerage, contract logistics, to temperature-controlled storage and specialized transport.
The IATA CEIV Pharma (Centre of Excellence for Independent Validators in Pharmaceutical Logistics) certification ensures that facilities, equipment, operations, and personnel meet the appropriate applicable standards, guidelines and regulations expected of a pharmaceutical manufacturer and logistics provider. It helps organizations and the entire air cargo supply chain achieve pharmaceutical handling excellence, while addressing the industry’s need for more safety, security, compliance, and efficiency through a globally consistent and recognized pharmaceutical-product handling certification.
* Source: Statista
GEODIS – www.geodis.com
GEODIS is a leading global logistics provider acknowledged for its expertise across all aspects of the supply chain. As a growth partner to its clients, GEODIS specializes in four lines of business: Global Freight Forwarding, Global Contract Logistics, Distribution & Express Transport, and European Road Network. With a global network spanning nearly 170 countries and 53 000 employees, GEODIS is ranked no. 5 in its sector across the world. In 2023, GEODIS generated €11.6 billion in revenue. GEODIS is a company owned by SNCF group.